Xinhua News Agency, May 31, China Resources double Crane announced that recently, China Resources Secco Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received the "Drug Registration Certificate" of Silodoxin capsule issued by the State Drug Administration to approve the production of the drug. Serodoxin capsule is suitable for the treatment of symptoms and signs caused by benign prostatic hyperplasia (BPH).